With a strong clinical-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, for example Retrocyte Screen™ and SECANT®, and innovative cell therapy strategies, positioning alone like a crucial contributor inside the biotechnology and immunotherapy arena.Our expense management business generates asset-centered service